Alder BioPharma files for $115M IPO, looks to use cash for migraine and arthritis treatments Seattle has seen a strong string of IPOs in the past few years — from Zillow to Tableau to Zulily.… Read More
Alder BioPharma raises $38M for cancer, migraine research In one of the largest venture capital rounds in the state so far this year, Bothell’s Alder BioPharmaceuticals has raised $38… Read More
